RadPharm Inc. CEO Ronald A. Berg Named Ernst & Young Entrepreneur Of The Year(R) 2008 Award Finalist in New Jersey

Wednesday, June 11, 2008 General News
Email Print This Page Comment bookmark
Font : A-A+

PRINCETON, N.J., June 11 RadPharm Inc., a leading imagingCRO, today announced that CEO Ronald A. Berg is a finalist for The New JerseyErnst & Young Entrepreneur Of The Year(R) 2008 Awards. According to Ernst &Young LLP, the awards program recognizes entrepreneurs who demonstrateextraordinary success in the areas of innovation, financial performance andpersonal commitment to their businesses and communities. Mr. Berg was selectedas a finalist from over 50 nominations by a panel of independent judges. Awardwinners will be announced at a special gala event on Thursday, June 19th, 2008at the Marriott Teaneck at Glenpointe, Teaneck, New Jersey.

"To be selected a finalist is an honor that is directly attributable toRadPharm as a company, as much as it is an honor to me personally," said Mr.Berg. "I'd like to recognize the founders of RadPharm, Drs. Robert Ford andDonald Rosen, as well as the nearly 300 employees whose efforts have earnedthe respect from pharmaceutical, biotech and medical device companies aroundthe world."

Mr. Berg has been CEO of RadPharm Inc. since 2002, playing a vital role inthe company's tremendous growth. Under his leadership, RadPharm hasexperienced record growth in revenue and contract awards, expanded its coreimage laboratory service offerings and opened a European location in Munich,Germany. Additionally, to accommodate the company's growing staff, RadPharmrecently expanded its headquarters in Princeton, NJ.

The Ernst & Young Entrepreneur Of The Year awards program celebrates its22nd anniversary this year. The program has expanded to recognize businessleaders in over 135 cities in 50 countries throughout the world.

Regional award winners are eligible for consideration for The Ernst &Young Entrepreneur Of The Year national program. Award winners in severalnational categories, as well as the overall national Ernst & YoungEntrepreneur Of The Year award winner, will be announced at the annual awardsgala in Palm Springs, California on November 15, 2008. The awards are theconcluding portion of Ernst & Young's Strategic Growth Forum, the nation'smost prestigious gathering of high-growth, market-leading companies.

For more information please contact Daja Herald at 609-936-2600.

About RadPharm Inc.

RadPharm, a leading imaging core lab, provides complete image managementservices to global pharmaceutical, biotechnology and medical deviceorganizations, facilitating successful new drug development. RadPharm employsfull-time, board certified, sub-specialty trained radiologists, nuclearphysicians and medical oncologists to focus on the Medicine Behind theImage(TM) and offer global trial sponsors medical expertise, advancedtechnology and proven operational processes to deliver accurate, timely trialdata. RadPharm has supported over 300 clinical trials across more than 60countries and 5000 unique sites.

For more information, please visit http://www.radpharm.com.

About Ernst & Young's Entrepreneur Of The Year

Ernst & Young's Entrepreneur Of The Year is the world's most prestigiousbusiness award for entrepreneurs. The award makes a difference through theunique way it encourages entrepreneurial activity among those with potentialand recognizes the contribution of people who inspire others with theirvision, leadership and achievement. As the first and only truly global awardof its kind, Ernst & Young Entrepreneur Of The Year celebrates those who arebuilding and leading successful, growing and dynamic businesses, recognizingthem through regional, national and global awards programs in more than 135cities in 50 countries.

About Ernst & Young

Ernst & Young is a global leader in assurance, tax, transaction andadvisory services. Worldwide, our 130,000 people are united by our sharedvalues and an unwavering commitment to quality. We make a difference byhelping our peopl

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store